Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.24.2.u1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Preferred Class B
Common Stock
Preferred Stock
Preferred Class B
Preferred Stock
Preferred Class C
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained (Deficit) Earnings
Noncontrolling Interest
Common stock, Beginning balance (in shares) at Dec. 31, 2022     26,462,000            
Beginning balance at Dec. 31, 2022 $ 707,244   $ 265     $ 270,855   $ 436,124  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 36,368             36,368  
Share-based compensation expense 3,149         3,149      
Payment of dividends to shareholders (6,345)         4   (6,349)  
Payment of minimum tax withholdings on share-based awards (in shares)     (40,000)            
Payment of minimum tax withholdings on share-based awards (4,292)             (4,292)  
Repurchases and retirement of common stock (in shares)     (474,000)            
Repurchases and retirement of common stock (50,491)   $ (5)         (50,486)  
Issuance of share-based awards (in shares)     105,000            
Issuance of share-based awards 0   $ 1     (1)      
Common stock, Ending balance (in shares) at Mar. 31, 2023     26,053,000            
Ending balance at Mar. 31, 2023 685,633   $ 261     274,007   411,365  
Common stock, Beginning balance (in shares) at Dec. 31, 2022     26,462,000            
Beginning balance at Dec. 31, 2022 707,244   $ 265     270,855   436,124  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss 56,319                
Net income 56,319                
Foreign currency translation adjustments 0                
Common stock, Ending balance (in shares) at Jun. 30, 2023     25,786,000            
Ending balance at Jun. 30, 2023 673,609   $ 258     277,593   395,758  
Common stock, Beginning balance (in shares) at Mar. 31, 2023     26,053,000            
Beginning balance at Mar. 31, 2023 685,633   $ 261     274,007   411,365  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss 19,951                
Net income 19,951             19,951  
Foreign currency translation adjustments 0                
Common stock issued under employee stock purchase plan (in shares)     4,000            
Common stock issued under employee stock purchase plan 421         421      
Share-based compensation expense 3,160         3,160      
Payment of dividends to shareholders (6,255)         5   (6,260)  
Repurchases and retirement of common stock (in shares)     (285,000)            
Repurchases and retirement of common stock (29,301)   $ (3)         (29,298)  
Issuance of share-based awards (in shares)     14,000            
Common stock, Ending balance (in shares) at Jun. 30, 2023     25,786,000            
Ending balance at Jun. 30, 2023 $ 673,609   $ 258     277,593   395,758  
Common stock, Beginning balance (in shares) at Dec. 31, 2023 25,670,663   25,671,000            
Preferred stock, Beginning balance (in shares) at Dec. 31, 2023   0   0 0        
Beginning balance, including noncontrolling interest at Dec. 31, 2023 $ 764,261   $ 257 $ 0 $ 0 283,684 $ 0 480,320 $ 0
Beginning balance at Dec. 31, 2023 764,261                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (88,794)             (61,712) (27,082)
Foreign currency translation adjustments (151)           (151)    
Shares issued - acquisition (in shares)     700,000 4,000 1,000        
Shares issued - acquisition 656,881   $ 7     223,425     433,449
Share-based compensation expense 1,567         1,567      
Payment of minimum tax withholdings on share-based awards (in shares)     (33,000)            
Payment of minimum tax withholdings on share-based awards (1,326)             (1,326)  
Issuance of share-based awards (in shares)     100,000            
Issuance of share-based awards 0   $ 1     (1)      
Common stock, Ending balance (in shares) at Mar. 31, 2024     26,438,000            
Preferred stock, Ending balance (in shares) at Mar. 31, 2024       4,000 1,000        
Ending balance, including noncontrolling interest at Mar. 31, 2024 $ 1,332,438   $ 265 $ 0 $ 0 508,675 (151) 417,282 406,367
Common stock, Beginning balance (in shares) at Dec. 31, 2023 25,670,663   25,671,000            
Preferred stock, Beginning balance (in shares) at Dec. 31, 2023   0   0 0        
Beginning balance, including noncontrolling interest at Dec. 31, 2023 $ 764,261   $ 257 $ 0 $ 0 283,684 0 480,320 0
Beginning balance at Dec. 31, 2023 764,261                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (1,060,141)                
Net income (707,145)                
Foreign currency translation adjustments $ (1,000)                
Common stock, Ending balance (in shares) at Jun. 30, 2024 27,698,891   27,699,000            
Preferred stock, Ending balance (in shares) at Jun. 30, 2024   12,105   12,000 0        
Ending balance, including noncontrolling interest at Jun. 30, 2024 $ 364,217   $ 277 $ 0 $ 0 512,638 (1,000) (228,151) 80,453
Ending balance at Jun. 30, 2024 283,764                
Common stock, Beginning balance (in shares) at Mar. 31, 2024     26,438,000            
Preferred stock, Beginning balance (in shares) at Mar. 31, 2024       4,000 1,000        
Beginning balance, including noncontrolling interest at Mar. 31, 2024 1,332,438   $ 265 $ 0 $ 0 508,675 (151) 417,282 406,367
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (971,347)             (645,433) (325,914)
Net income (645,433)                
Foreign currency translation adjustments (849)           (849)    
Common stock issued under employee stock purchase plan (in shares)     21,000            
Common stock issued under employee stock purchase plan 355         355      
Conversion of preferred C series (in shares)     1,210,000 8,000 (1,000)        
Conversion of preferred C series 0   $ 12     (12)      
Share-based compensation expense 3,620         3,620      
Issuance of share-based awards (in shares)     30,000            
Issuance of share-based awards $ 0                
Common stock, Ending balance (in shares) at Jun. 30, 2024 27,698,891   27,699,000            
Preferred stock, Ending balance (in shares) at Jun. 30, 2024   12,105   12,000 0        
Ending balance, including noncontrolling interest at Jun. 30, 2024 $ 364,217   $ 277 $ 0 $ 0 $ 512,638 $ (1,000) $ (228,151) $ 80,453
Ending balance at Jun. 30, 2024 $ 283,764